main_id,nct_id,drks_id,ictrp_id,created_at,des_q,des_a,des_c,des_c_error_type,inc_q,inc_a,inc_a_errtype,inc_c,inc_a_error_type,int_q,int_a,int_c,int_a_error_type,pri_q,pri_a,pri_c,pri_a_error_type,sec_q,sec_a,sec_c,sec_a_error_type
3045,NCT02986503,NA,NCT02986503,NCT: 2016-11-25 ICTRP: 2016-11-25 DRKS: NA,1,1,NA,,1,1,NA,NA,,NA,NA,NA,,4,1,Progression not defined,,4,0,Progression not defined; not reported,not reported
3803,NCT02771535,NA,NCT02771535,NCT: 2016-04-05 ICTRP: 2016-04-05 DRKS: NA,1,1,NA,,1,1,NA,No cutpoint for MINI,,2,1,NA,,4,1,No AM; Follow up after 3 instead of 3.5 years,,5,0,Follow up after 3.5 instead of 3 years. Outcome 7 (remission rate) not reported,not reported
15470,NCT00571948,NA,NCT00571948,NCT: 2007-12-11 ICTRP: 2007-12-11 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,Meat percentage in intervention 2 not 13% (as registered) but 12%,different dosage,5,1,NA,,4,0,no AM; dietary intake not reported,not reported
13866,NCT00865501,NA,NCT00865501,NCT: 2009-03-18 ICTRP: 2009-03-18 DRKS: NA,1,0,"Maybe the paper is a byproduct of the registered trial, but it does not follow the registered design, interventions and outcomes.",different design,2,1,NA,NA,,2,0,,different intervention,3,0,"no AM, no metric; not found",not reported,NA,NA,NA,
18712,NCT00069095,NA,NCT00069095,NCT: 2003-09-15 ICTRP: 2003-09-15 DRKS: NA,1,1,NA,,1,1,NA,Criteria more specific in paper,,2,1,NA,,5,1,NA,,4,0,no AM; not reported,not reported
18649,NCT00079482,NA,NCT00079482,NCT: 2004-03-08 ICTRP: 2004-03-08 DRKS: NA,1,0,"Paper reports crossover of patients given specific circumstances, but not registered.",different design,2,1,NA,NA,,2,1,NA,,4,1,no measure,,4,1,no measure,
18029,NCT00171873,NA,NCT00171873,NCT: 2005-09-13 ICTRP: 2005-09-13 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,"intervals given, no time frame",,4,1,no measure (definition of progression),,5,0,Follow-up after 6 instead of 3 months,different time frame
27202,NCT00168454,DRKS00004022,DRKS00004022,NCT: NA ICTRP: 2012-07-03 DRKS: 2012-07-03,1,1,NA,,1,1,a,NA,,2,1,NA,,5,1,NA,,5,0,Additional scales: KHQ and SF-36. MCC (that is outcome 3) not assessed. Different time frames for number of micturitions.,different time frame
18045,NCT00171067,NA,NCT00171067,NCT: 2005-09-10 ICTRP: 2005-09-10 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,NA,,4,1,"no AM; Can UACR be regarded the same as ""albumin exretion""?",,3,0,"Registration: no AM, no measure (definition of blood test); Paper: Endpoint 2 of 3 not assessed. Unclear to the rater whether the other endpoints were assessed.",not reported
18166,NCT00153530,NA,NCT00153530,NCT: 2005-09-08 ICTRP: 2005-09-08 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,"Details on intervention from study description; MTX was given identical to protocol, but additionally ifosfamide, mentioned as protocol amendment in paper.",additional medicine (acknowledged),5,1,NA,,4,1,no measure,
15095,NCT00654719,NA,NCT00654719,NCT: 2008-04-03 ICTRP: 2008-04-03 DRKS: NA,1,1,NA,,2,0,NA,"Cutpoint for inclusion changed from >= 3 to ""with stable HF New
York Heart Association (NYHA) functional  class II–IV"".",different cutpoint,2,1,NA,,3,1,"no AM, no metric",,3,1,"no AM, no metric",
9103,NCT01645150,NA,NCT01645150,NCT: 2012-06-11 ICTRP: 2012-06-11 DRKS: NA,1,1,NA,,1,1,NA,NA,,1,1,NA,,4,0,no AM; Identified as secondary endpoint in paper,outcome switched to secondary,4,1,no AM,
5466,NCT02397473,NA,NCT02397473,NCT: 2015-03-19 ICTRP: 2015-03-19 DRKS: NA,1,1,NA,,2,0,NA,"Inclusion criteria differ a bit, for example register ""with a history of episodic cluster headache with at least two cluster periods lasting from 7 days to 1 year (when untreated) and separated by pain-free remission periods of >=1 month"" vs. In article ""required to have had a cluster headache period that had lasted at least 6 weeks""",different cutpoint,2,1,NA,,5,1,NA,,5,1,NA,
12191,NCT01147185,NA,NCT01147185,NCT: 2010-05-07 ICTRP: 2010-05-07 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,1,NA,,4,0,"no AM; not reported, also 6-month-follow-up not reported (mentioned as limitation in the article)",not reported (acknowledged),5,0,no AM; not reported due to data sparsity (metioned as limitation in paper),not reported (acknowledged)
25359,NCT02021409,DRKS00006416,DRKS00006416,NCT: NA ICTRP: 2014-11-03 DRKS: 2014-11-03,1,1,NA,,2,0,NA,Mean Hb lower value 9 in article instead of 10,different cutpoint,1,1,NA,,4,1,no AM,,5,1,NA,
8253,NCT01806298,NA,NA,NCT: 2013-03-05 ICTRP: NA DRKS: NA,1,1,NA,,2,0,NA,"BMI cutoff 40 in article, 35 in register",different cutpoint,1,1,NA,,5,1,NA,,5,1,NA,
35016,NCT02946463,NA,EUCTR2016-002025-11,NCT: NA ICTRP: 2016-10-07 DRKS: NA,1,1,NA,,2,1,NA,NA,,2,0,"extension period for therapy 5 years in register, 2 years in article",different extension period,5,1,NA,,4,1,no AM,
16730,NCT00388505,NA,NCT00388505,NCT: 2006-10-16 ICTRP: 2006-10-16 DRKS: NA,1,1,NA,,1,1,r,definition of fibrosis; criteria more specific in register,,2,1,NA,,5,1,NA,,5,0,not reported,not reported
8492,NCT01760083,NA,NCT01760083,NCT: 2013-01-01 ICTRP: 2013-01-01 DRKS: NA,1,1,NA,,2,0,NA,CTO location 12 missing in article,missing criterion,2,1,NA,,4,1,no AM,,4,1,no AM,
17907,NCT00191516,NA,NCT00191516,NCT: 2005-09-12 ICTRP: 2005-09-12 DRKS: NA,1,1,NA,,1,0,NA,"In register children 6-12, in article 6-17y",different age range,2,1,"info from description; target dose correct, but could be adjusted within a range according to article",,4,1,no AM,,4,0,no AM; PAERS not reported,not reported
11984,NCT01182428,NA,NCT01182428,NCT: 2010-07-13 ICTRP: 2010-07-13 DRKS: NA,1,1,NA,,2,0,"NA; Typo? Target lesion <28mm in article, but >28mm in register",NA,different cutpoint,1,1,NA,,5,1,NA,,5,1,NA,
14566,NCT00740896,NA,NCT00740896,NCT: 2008-08-22 ICTRP: 2008-08-22 DRKS: NA,1,1,NA,,2,0,NA,age range 20-50 in article instead of >18,different age range,2,1,NA,,3,0,"no AM, time frame seems incorrect",different time frame,4,0,time frame seems incorrect,different time frame
22868,NA,DRKS00011712,DRKS00011712,NCT: NA ICTRP: 2017-02-06 DRKS: 2017-02-06,1,1,NA,,1,1,NA,NA,,NA,NA,NA,,4,0,"no AM; Minimal differences between cutpoints in published paper and in register: Acromionslope >=25,7°; Acromionindex >=0,73 vs.  acromion slope 25.0° or more, AI 0,75 or more.",different cutpoints,1,1,"no AM, no metric, no time frame, no measure",
23542,NA,DRKS00009614,DRKS00009614,NCT: NA ICTRP: 2016-06-27 DRKS: 2016-06-27,1,1,NA,,1,1,NA,NA,,2,1,NA,,3,1,Scale and aggregation missing. Details from description,,4,0,Aggregation Method missing; Article: One day difference in follow-up length,different time frame
26866,NA,DRKS00002426,DRKS00002426,NCT: NA ICTRP: 2012-11-19 DRKS: 2012-11-19,1,1,NA,,1,1,r,NA,,2,1,NA,,4,1,no measure,,4,0,"no measure; best response reported only at end of study, not at all timepoints that are mentioned in register",different time frame
24160,NA,DRKS00009741,DRKS00009741,NCT: NA ICTRP: 2015-12-04 DRKS: 2015-12-04,1,1,NA,,2,1,NA,NA,,2,0,"NA; Different intervention, but this is the paper linked as ""publication"" in the registry",different intervention,4,0,no AM,,4,1,no AM,
28850,NA,NA,ISRCTN97265367,NCT: NA ICTRP: 2008-04-04 DRKS: NA,1,1,NA,,2,1,r,Criteria more specific in register,,2,1,NA,,4,1,Aggregation Method missing,,4,0,Aggregation Method missing; Article: Not reported.,not reported
28918,NA,NA,ISRCTN03693000,NCT: NA ICTRP: 2007-09-27 DRKS: NA,1,0,"Registration mentions ""partial cross-over"" design, but this is not reported or did not take place",different design,2,0,r,"NA; Age 18-65 (with exceptions for older patients) in register, 19-72 in article. ""Participants with mild depressive symptoms on antidepressant treatment can be included if there is a history of moderate or severe symptoms during the current depressive episode"" only mentioned in register",different age range,2,0,NA; maximum dose of Nortriptyline differs,,5,0,NA; First primary outcome not reported,not reported,4,0,no AM; not reported,not reported
29207,NA,NA,ISRCTN55261332,NCT: NA ICTRP: 2005-10-10 DRKS: NA,1,1,NA,,2,1,NA,NA,,1,1,no dosages,,3,0,"no AM, time frame unclear; Primary outcome changed, reasons are given in the article",outcome modified (acknowledged),3,1,"no AM, no time frame",
28190,NA,NA,ISRCTN60475069,NCT: NA ICTRP: 2010-09-15 DRKS: NA,1,1,NA,,1,1,NA,NA,,2,1,NA,,4,1,no measure,,4,0,"no AM; SCORAD was assessed according to article, but not reported",not reported